Phathom Pharmaceuticals
PHAT
PHAT
144 hedge funds and large institutions have $541M invested in Phathom Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 60 increasing their positions, 26 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
42% less funds holding in top 10
Funds holding in top 10: 12 → 7 (-5)
59% less capital invested
Capital invested by funds: $1.31B → $541M (-$771M)
91% less call options, than puts
Call options by funds: $455K | Put options by funds: $5.2M
Holders
144
Holding in Top 10
7
Calls
$455K
Puts
$5.2M
Top Buyers
| 1 | +$10.7M | |
| 2 | +$9.71M | |
| 3 | +$6.25M | |
| 4 |
Morgan Stanley
New York
|
+$4.28M |
| 5 |
TCM
Tang Capital Management
San Diego,
California
|
+$4.06M |
Top Sellers
| 1 | -$30.7M | |
| 2 | -$26.2M | |
| 3 | -$25.4M | |
| 4 |
SVCM
Saturn V Capital Management
Austin,
Texas
|
-$15.8M |
| 5 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$13.2M |